Ticker
LEXXCompany Name
LEXARIA BIOSCIENCE CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 615.92K | $ 833.28K | 135.29% |
3/31/2025 | $ 525.92K | $ 704.92K | 134.03% |
12/31/2024 | $ 496.92K | $ 537.7K | 108.21% |
9/30/2024 | $ 464.28K | $ 492.24K | 106.02% |
6/30/2024 | $ 376.85K | $ 405.36K | 107.57% |
3/31/2024 | $ 386K | $ 145.03K | 37.57% |
12/31/2023 | $ 276.01K | $ 155.56K | 56.36% |
9/30/2023 | $ 226.21K | $ 170.38K | 75.32% |
6/30/2023 | $ 340.79K | $ 393.62K | 115.5% |
3/31/2023 | $ 347.36K | $ 423.35K | 121.88% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for LEXARIA BIOSCIENCE CORP is calculated as follows: SB Comp. [ $ 1.14M ] / Revenues [ $ 384.54K ]
(=) SB Comp % [ 296.27% ]
Minimum
Mar 31, 2024
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |